CD-GANs: GANs条件动态训练增强钆后胶质母细胞瘤mri

IF 2 4区 医学 Q2 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Aymen Ahriz , Rachida Saouli , Lara Raad , Jean Cousty
{"title":"CD-GANs: GANs条件动态训练增强钆后胶质母细胞瘤mri","authors":"Aymen Ahriz ,&nbsp;Rachida Saouli ,&nbsp;Lara Raad ,&nbsp;Jean Cousty","doi":"10.1016/j.mri.2025.110509","DOIUrl":null,"url":null,"abstract":"<div><div>Gliomas are brain tumors originating from glial cells, graded I to IV by the WHO, with Grade IV glioblastoma (GBM) being the most aggressive. Magnetic resonance imaging (MRI) is crucial for monitoring disease progression and guiding therapy in glioma patients. However, gadolinium, a contrast agent used for visualization, poses risks of accumulation, particularly in patients with nephrogenic systemic fibrosis, renal disease, diabetic nephropathy, or low glomerular filtration rate. This underscores the need for innovative imaging solutions. This paper proposes a method for generating synthetic T1-weighted Contrast-Enhanced (T1CE) images, enabling tumor visualization without gadolinium injection. This approach aims to improve patient outcomes by accurately delineating tumor characteristics while avoiding gadolinium-related risks. We introduce a Generative Adversarial Network (GAN) for T1CE MRI synthesis, utilizing a dynamic training mechanism with condition-based discriminators adjusted based on tumor presence in each batch. This ensures precise T1CE image synthesis. Furthermore, this work introduces progressive intensity training, which prioritizes learning from dark intensity regions before gradually incorporating medium and light intensities, enhancing fine detail capture. This strategy is applied to Pix2pix and our two frameworks, Conditional-Patch Discriminator (CPD-GAN) and Double Conditional Discriminators (DCD-GAN), resulting in their progressive intensity versions: PiPix2pix, PiCPD-GAN, and PiDCD-GAN. Validated on the Brats2020 dataset, the proposed methodology demonstrates superior performance in multi-modality imaging compared to state-of-the-art methods. Experimental results, particularly for DCD-GAN and its Pi variant, highlight their effectiveness in T1CE image synthesis, offering a safer and more reliable alternative for glioma diagnosis and monitoring.</div></div>","PeriodicalId":18165,"journal":{"name":"Magnetic resonance imaging","volume":"124 ","pages":"Article 110509"},"PeriodicalIF":2.0000,"publicationDate":"2025-08-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"CD-GANs : Conditional dynamic training with GANs for enhanced post-gadolinium glioblastoma MRIs\",\"authors\":\"Aymen Ahriz ,&nbsp;Rachida Saouli ,&nbsp;Lara Raad ,&nbsp;Jean Cousty\",\"doi\":\"10.1016/j.mri.2025.110509\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Gliomas are brain tumors originating from glial cells, graded I to IV by the WHO, with Grade IV glioblastoma (GBM) being the most aggressive. Magnetic resonance imaging (MRI) is crucial for monitoring disease progression and guiding therapy in glioma patients. However, gadolinium, a contrast agent used for visualization, poses risks of accumulation, particularly in patients with nephrogenic systemic fibrosis, renal disease, diabetic nephropathy, or low glomerular filtration rate. This underscores the need for innovative imaging solutions. This paper proposes a method for generating synthetic T1-weighted Contrast-Enhanced (T1CE) images, enabling tumor visualization without gadolinium injection. This approach aims to improve patient outcomes by accurately delineating tumor characteristics while avoiding gadolinium-related risks. We introduce a Generative Adversarial Network (GAN) for T1CE MRI synthesis, utilizing a dynamic training mechanism with condition-based discriminators adjusted based on tumor presence in each batch. This ensures precise T1CE image synthesis. Furthermore, this work introduces progressive intensity training, which prioritizes learning from dark intensity regions before gradually incorporating medium and light intensities, enhancing fine detail capture. This strategy is applied to Pix2pix and our two frameworks, Conditional-Patch Discriminator (CPD-GAN) and Double Conditional Discriminators (DCD-GAN), resulting in their progressive intensity versions: PiPix2pix, PiCPD-GAN, and PiDCD-GAN. Validated on the Brats2020 dataset, the proposed methodology demonstrates superior performance in multi-modality imaging compared to state-of-the-art methods. Experimental results, particularly for DCD-GAN and its Pi variant, highlight their effectiveness in T1CE image synthesis, offering a safer and more reliable alternative for glioma diagnosis and monitoring.</div></div>\",\"PeriodicalId\":18165,\"journal\":{\"name\":\"Magnetic resonance imaging\",\"volume\":\"124 \",\"pages\":\"Article 110509\"},\"PeriodicalIF\":2.0000,\"publicationDate\":\"2025-08-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Magnetic resonance imaging\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0730725X25001936\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Magnetic resonance imaging","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0730725X25001936","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0

摘要

胶质瘤是源自神经胶质细胞的脑肿瘤,WHO将其划分为I至IV级,其中IV级胶质母细胞瘤(GBM)最具侵袭性。核磁共振成像(MRI)对监测胶质瘤患者的疾病进展和指导治疗至关重要。然而,钆,一种用于可视化的造影剂,有积聚的风险,特别是在肾源性系统性纤维化、肾病、糖尿病肾病或肾小球滤过率低的患者中。这凸显了对创新成像解决方案的需求。本文提出了一种生成合成t1加权对比增强(T1CE)图像的方法,使肿瘤可视化无需注射钆。该方法旨在通过准确描述肿瘤特征来改善患者预后,同时避免钆相关风险。我们引入了一种用于T1CE MRI合成的生成对抗网络(GAN),利用基于条件的鉴别器的动态训练机制,根据每批中肿瘤的存在进行调整。这确保了精确的T1CE图像合成。此外,这项工作还引入了渐进式强度训练,该训练优先从暗强度区域学习,然后逐渐结合中强度和光强度,增强细节捕捉。该策略应用于Pix2pix和我们的两个框架,条件补丁鉴别器(CPD-GAN)和双条件鉴别器(DCD-GAN),产生了它们的渐进强度版本:PiPix2pix, PiCPD-GAN和PiDCD-GAN。在Brats2020数据集上验证,与最先进的方法相比,所提出的方法在多模态成像方面表现出优越的性能。实验结果,特别是DCD-GAN及其Pi变体,突出了它们在T1CE图像合成中的有效性,为胶质瘤的诊断和监测提供了更安全、更可靠的替代方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
CD-GANs : Conditional dynamic training with GANs for enhanced post-gadolinium glioblastoma MRIs
Gliomas are brain tumors originating from glial cells, graded I to IV by the WHO, with Grade IV glioblastoma (GBM) being the most aggressive. Magnetic resonance imaging (MRI) is crucial for monitoring disease progression and guiding therapy in glioma patients. However, gadolinium, a contrast agent used for visualization, poses risks of accumulation, particularly in patients with nephrogenic systemic fibrosis, renal disease, diabetic nephropathy, or low glomerular filtration rate. This underscores the need for innovative imaging solutions. This paper proposes a method for generating synthetic T1-weighted Contrast-Enhanced (T1CE) images, enabling tumor visualization without gadolinium injection. This approach aims to improve patient outcomes by accurately delineating tumor characteristics while avoiding gadolinium-related risks. We introduce a Generative Adversarial Network (GAN) for T1CE MRI synthesis, utilizing a dynamic training mechanism with condition-based discriminators adjusted based on tumor presence in each batch. This ensures precise T1CE image synthesis. Furthermore, this work introduces progressive intensity training, which prioritizes learning from dark intensity regions before gradually incorporating medium and light intensities, enhancing fine detail capture. This strategy is applied to Pix2pix and our two frameworks, Conditional-Patch Discriminator (CPD-GAN) and Double Conditional Discriminators (DCD-GAN), resulting in their progressive intensity versions: PiPix2pix, PiCPD-GAN, and PiDCD-GAN. Validated on the Brats2020 dataset, the proposed methodology demonstrates superior performance in multi-modality imaging compared to state-of-the-art methods. Experimental results, particularly for DCD-GAN and its Pi variant, highlight their effectiveness in T1CE image synthesis, offering a safer and more reliable alternative for glioma diagnosis and monitoring.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Magnetic resonance imaging
Magnetic resonance imaging 医学-核医学
CiteScore
4.70
自引率
4.00%
发文量
194
审稿时长
83 days
期刊介绍: Magnetic Resonance Imaging (MRI) is the first international multidisciplinary journal encompassing physical, life, and clinical science investigations as they relate to the development and use of magnetic resonance imaging. MRI is dedicated to both basic research, technological innovation and applications, providing a single forum for communication among radiologists, physicists, chemists, biochemists, biologists, engineers, internists, pathologists, physiologists, computer scientists, and mathematicians.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信